文献速递青光眼

肾上腺素能通路介导大鼠昼夜眼压节律

Adrenergic Pathways Mediate Circadian IOP Rhythm in Rats.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

本研究在大鼠中通过无线遥测连续监测眼压,在持续黑暗条件下于主观白天和主观夜间局部滴用β、α1和α2受体激动剂与拮抗剂,发现多条肾上腺素能受体通路参与昼夜眼压调节;夜间眼压升高需要所有通路共同参与,而β和α1受体单独激活即可在白天将眼压升至夜间水平。

要点

  • 夜间滴用噻吗洛尔、布那唑嗪、育亨宾或溴莫尼定均使眼压显著下降,白天滴用则无变化。
  • 白天滴用去氧肾上腺素或异丙肾上腺素使眼压显著升高,夜间滴用则无变化。
  • 布那唑嗪可消除眼压节律数日,但所有药物均未改变节律周期或相位。

核心结论

  • 多条肾上腺素能受体通路共同参与大鼠眼压的昼夜节律调节。
  • 夜间眼压升高需要所有通路共同参与,任一路路失活均使眼压完全回落至白天水平。
  • β和α1受体激活单独即可在白天将眼压升至夜间水平,α2受体作用更复杂。

研究设计与样本

  • 成年Brown-Norway大鼠先置于明暗循环,后维持持续黑暗环境。
  • 通过无线遥测连续监测眼压。
  • 在持续黑暗的主观白天和主观夜间角膜局部滴用β、α1和α2受体激动剂与拮抗剂。

主要发现

  • 动物在明暗循环中呈现明显眼压节律,并在持续黑暗中维持。
  • 主观夜间滴用噻吗洛尔(DSN% = -110% ± 24%)、布那唑嗪(DSN% = -107% ± 13%)、育亨宾(DSN% = -106% ± 12%)和溴莫尼定(DSN% = -94% ± 18%)后眼压显著降低,主观白天滴用无变化。
  • 主观白天滴用去氧肾上腺素(DSD% = 143% ± 62%)和异丙肾上腺素(DSD% = 62% ± 19%)后眼压显著升高,主观夜间滴用无变化。
  • 所有药物均未改变眼压节律的周期或相位,但布那唑嗪使节律消失数日。

临床怎么用

  • 提示降眼压药物疗效可能受给药时间影响,夜间给药对β和α1受体拮抗剂降眼压效果更明显。
  • α1受体拮抗剂布那唑嗪可能干扰眼压节律,临床用药需关注昼夜眼压波动。

局限性

  • 研究为大鼠动物实验,结果向人类临床转化需谨慎。
  • 药物效应以短期平均眼压变化和长期节律变化量化,未涉及其他物种或长期安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study sought to define adrenergic receptor mechanisms underlying circadian intraocular pressure (IOP) regulation in rats. METHODS: IOP was monitored continuously via wireless telemetry in adult Brown-Norway rats entrained to the ambient light/dark (LD) cycle and then maintained in constant darkness (DD). Agonists and antagonists of β- (isoproterenol and timolol), α1- (phenylephrine and bunazosin), and α2- (brimonidine and yohimbine) receptors were applied topically to the cornea during subjective day (SD) and subjective night (SN) in DD. Drug effects were quantified by short-term changes in mean IOP and long-term changes in IOP rhythmicity. RESULTS: Animals exhibited a pronounced IOP rhythm in LD that persisted in DD. IOP was significantly reduced after SN instillation of timolol (DSN% = -110% ± 24%), bunazosin (DSN% = -107% ± 13%), yohimbine (DSN% = -106% ± 12%), and brimonidine (DSN% = -94% ± 18%) and was unchanged after SD instillation. Conversely, IOP was significantly elevated after SD instillation of phenylephrine (DSD% = 143% ± 62%) and isoproterenol (DSD% = 62% ± 19%) and was unchanged after SN instillation. None of the drugs altered IOP rhythm period or phase, but bunazosin abolished the rhythm for several days. CONCLUSIONS: Multiple adrenergic receptor pathways participate in the circadian regulation of rat IOP. All are necessary to raise IOP during SN since inactivation of any individual pathway drops IOP fully back to daytime levels. β- and α1-receptor activation is also singularly sufficient to raise IOP during SD to nighttime levels, whereas α2-receptors play a more complex role in IOP regulation.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Zamitalo-Pomares A, Passaglia CL. Adrenergic Pathways Mediate Circadian IOP Rhythm in Rats. Invest Ophthalmol Vis Sci. 2026. PMID: 42770657. doi:10.1167/iovs.67.11.41

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。